Topcell Bio Receives Green Light for KOSDAQ Listing: Preliminary Examination Passed, Public Listing Expected in the Second Half of This Year

Cell Bio” Enter Topcell BioCosdaq Green Light” Preliminary examination of listing on Korea Exchange passed, listing within the second half of this year.

A green light has been turned on for the listing of Top Cell Bio KOSDAQ, a cell bio company.

The KOSDAQ Market Headquarters of the Korea Exchange approved a preliminary review of Top Cell Bio KOSDAQ listing after deliberation and resolution by the KOSDAQ Market Listing Committee.

It will be listed by the end of this year through a roundabout listing through a merger with KOSPI-listed company J.

Founded in 2008, Top Cell Bio provides long-term storage of dental stem cells and oral fibroblasts and uses stored dental (nerve) cells.

In the near future, through the above technologies, such as regenerative medical applications such as bones, cartilage, gums, nerves, blood vessels, and muscle skin, and oral fibroblasts are used to apply to skin beauty. It is expected to stand tall in bio companies.

More than half of its sales come from the U.S. and China. It is currently operating in China, the U.S., and Southeast Asia, with about 82 percent of its sales coming from overseas last year.

Top Cell Bio plans to go public in the second half of this year through Daishin Securities, a listed company.